SCHEMBL4757380

SCHEMBL4757380

CCc1cccc(C(=O)Nc2ncc(NS(C)(=O)=O)s2)c1O

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
STAT3 P40763 2/20 0.46
ALDH1A1 P00352 5/20 0.42
KDM4E B2RXH2 2/20 0.41
HSD17B10 Q99714 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
MAPT P10636 1/20 0.38
CRHBP P24387 1/20 0.38
CRHR2 Q13324 1/20 0.38
LMNA P02545 1/20 0.38
GAA P10253 1/20 0.38
POLQ O75417 1/20 0.37
GRM4 Q14833 2/20 0.37
TSHR P16473 1/20 0.37
TDP1 Q9NUW8 1/20 0.36
FBP1 P09467 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4757439 0.85 ALDH1A1 (0.42) STAT3ALDH1A1KDM4EHSD17B10SMN1; SMN2
SCHEMBL4756542 0.84 STAT3 (0.47) STAT3ALDH1A1KDM4ESMN1; SMN2NPC1
SCHEMBL4757379 0.83 STAT3 (0.56) STAT3ALDH1A1KDM4EHSD17B10SMN1; SMN2
SCHEMBL10131682 0.80 STAT3 (0.50) STAT3ALDH1A1KDM4EHSD17B10SMN1; SMN2
SCHEMBL4755842 0.78 STAT3 (0.47) STAT3ALDH1A1KDM4ENPC1RAB9A
SCHEMBL4757381 0.76 STAT3 (0.60) STAT3ALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL4757387 0.75 KCNMA1 (0.54) STAT3
SCHEMBL10114640 0.75 STAT3 (0.43) STAT3MEN1KMT2APOLQ
SCHEMBL4757427 0.73 ALDH1A1 (0.47) STAT3ALDH1A1KDM4EHSD17B10SMN1; SMN2
SCHEMBL4756660 0.71 RAB9A (0.48) STAT3ALDH1A1KDM4EHSD17B10SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES, L.C. 2012-05-17 US disclosed
US-8124632-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES, L.C. (US) 2012-02-28 US disclosed
US-20090036467-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES L.C. 2009-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC STAT3 63/4885ALDH1A1 1605/4885KDM4E 2428/4885
US-20090036467-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC STAT3 63/4885ALDH1A1 1605/4885KDM4E 2428/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.